US 11938174
Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders
granted A61KA61K35/16A61K38/55
Quick answer
US patent 11938174 (Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders) held by Takeda Pharmaceutical Company Limited expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K35/16, A61K38/55, A61K38/57, A61K39/3955